Journal profile · Medicine-Pathology and Forensic Medicine
Iranian Journal of Pathology
ISSN 1735-5303 · eISSN 2345-3656 · Iranian Society of Pathology · Canada
Iranian Journal of Pathology: fully open access; APC about USD 182; median 101 days to acceptance (90 articles, last 24 months); acceptance rate 26% (journal website); 84 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Iranian Journal of Pathology is published by Iranian Society of Pathology. By OpenAlex counts of its recent articles, its largest topics are Breast Lesions and Carcinomas, Breast Cancer Treatment Studies and Antibiotic Resistance in Bacteria, together about 23% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Iranian Journal of Pathology (Iran J Pathol) is a quarterly, peer-reviewed, fully open-access journal dedicated to the publication of high-quality scholarly work in pathology and related biomedical sciences. The journal welcomes submissions from authors worldwide and serves an international community of researchers, pathologists, clinicians, laboratory scientists, reviewers, editors, and readers. The journal publishes original research articles, review articles, case reports, short communications, letters to the editor, and other scholarly contributions within the scope of pathology and disease-related biomedical research. Priority is given to scientifically rigorous studies that improve understanding of disease mechanisms, diagnostic methods, clinicopathological correlations, molecular and cellular pathology, laboratory medicine, and translational aspects of human disease and Pathophysiology.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pathology and Forensic Medicine
Editor-in-chief Mohammadreza Jalali NadoushanPublisher website
Editorial board by country: none in mainland China; most named India 4, Iran 2, Türkiye 2 (8 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Lesions and CarcinomasMedicine8.9%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology8.3%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology5.8%
- Sarcoma Diagnosis and TreatmentMedicine5.7%
- Head and Neck Cancer StudiesMedicine5%
- Ovarian cancer diagnosis and treatmentMedicine4.6%
- Metastasis and carcinoma case studiesMedicine4.4%
- Clinical Laboratory Practices and Quality ControlMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pathology and Forensic Medicine | Q3 | 140/209 | 33rd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.3LetPub ·
- SNIP 2026-06
- 0.37LetPub ·
- h-index
- 26OpenAlex ·
- i10-index
- 143OpenAlex ·
- 2-year mean citedness
- 1.28OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Downloads per year (publisher) 2025
- 1061.76Publisher website ·
Articles by year OpenAlex count · 849 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 389 |
| 2025 | 84 | 84 | 556 |
| 2024 | 62 | 62 | 568 |
| 2023 | 59 | 59 | 619 |
| 2022 | 64 | 64 | 635 |
| 2021 | 49 | 49 | 516 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
101 daysMedian, submission to acceptance · P25–P75 66 days – 153 days
- Acceptance to online
- median 49 days (94 articles)
- Submission to online
- median 170 days
- Sample
- 90 articles with submission and acceptance dates (139 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 20 weeksLetPub ·
- Acceptance rate (publisher) 2025
- 26%Publisher website ·
- Submission to first decision 2025
- 30 daysPublisher website ·
- Peer review
- Double anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | CAD 250 | — | — | |
| LetPub | CAD 250 | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- case reportCase ReportLength not stated
- review articleReview ArticleLength not stated
- short communicationShort CommunicationLength not stated
- systematic reviewSystematic ReviewLength not stated
Policy excerpts from the journal's websiteData availability, Peer review
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Iranian Society of Pathology
- Country or region
- Canada
- Language
- English
- ISSN
- 1735-5303
- Electronic ISSN
- 2345-3656
- Latest issue on the website
- Volume 21, Issue 4 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Iranian Journal of Pathology
How long does peer review take at Iranian Journal of Pathology?
Based on the dates recorded on 90 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 101 days (interquartile range 66–153 days); authors report an average review time of about 20 weeks; the journal's website gives an acceptance rate of 26% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Iranian Journal of Pathology based?
Of the 8 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (4), Iran (2) and Türkiye (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Iranian Journal of Pathology?
According to LetPub and DOAJ records, Iranian Journal of Pathology is indexed in Scopus.
Is Iranian Journal of Pathology open access, and what is the APC?
Iranian Journal of Pathology is a fully open-access journal. APC about USD 182.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .